Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinoma

Keywords

Humanities, Political science, Philosophy

References

• BAP1 loss defines a new class of renal cell carcinomaJosé María Martínez Cachero — 2012
• Impact of pathological tumour characteristics in patients with sarcomatoid renal cell carcinomaBrian Shuch, Gennady Bratslavsky, Joanna H. Shih — 2012
• Sensitive detection of somatic point mutations in impure and heterogeneous cancer samplesKristian Cibulskis, Michael S. Lawrence, Scott L. Carter — 2013
• Whole exome sequencing identifies a recurrent RQCD1 P131L mutation in cutaneous melanomaStephen Q. Wong, Andreas Behren, Victoria Mar — 2014
• Predicting Functional Effect of Human Missense Mutations Using PolyPhen-2Ivan Adzhubei, Daniel M. Jordan, Shamil Sunyaev — 2013
• TSG101 protein steady-state level is regulated posttranslationally by an evolutionarily conserved COOH-terminal sequence.G H Feng, Chih‐Jian Lih, Stanley N. Cohen — 2000
• Clonal expansion and attenuated apoptosis in Wilms' tumors are associated with p53 gene mutations.Nabeel Bardeesy, J. Bruce Beckwith, Jerry Pelletier — 1995
• A novel prognostic model for patients with sarcomatoid renal cell carcinomaBen Y. Zhang, R. Houston Thompson, Christine M. Lohse — 2015
• Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumorsGerald Goh, Ute I. Scholl, James M. Healy — 2014
• Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencingMarco Gerlinger, Stuart Horswell, James Larkin — 2014
• Ptk7 Marks the First Human Developmental EMT In VitroDavid N. Chan, Soheila Azghadi, Jun Feng — 2012
• Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activationLuc G.T. Morris, Andrew Kaufman, Yongxing Gong — 2013
• Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinomaSiming Zhao, Murim Choi, John D. Overton — 2013
• Active chemotherapy for sarcomatoid and rapidly progressing renal cell carcinomaDavid M. Nanus, A. Garino, Matthew I. Milowsky — 2004
• The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic ParametersBrett Delahunt, John C. Cheville, Guido Martignoni — 2013
• Function and cancer genomics of FAT family genesMasaru Katoh — 2012
• Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancerColin C. Pritchard, Colm Morrissey, Akash Kumar — 2014
• Mammalian Rcd1 is a novel transcriptional cofactor that mediates retinoic acid‐induced cell differentiationNoriko Hiroi, Takaaki Ito, Hanako Yamamoto — 2002
• Sarcomatoid renal carcinoma: the final common dedifferentiation pathway of renal epithelial malignancies.Brett Delahunt — 1999
• Clinically Non-Metastatic Renal Cell Carcinoma With Sarcomatoid Dedifferentiation: Natural History and Outcomes after Surgical Resection with Curative IntentMegan M. Merrill, Christopher G. Wood, Nizar M. Tannir — 2015

Cited by

• Precision medicine from the renal cancer genome典子 井上, 洋二郎 大成, 美由紀 久保 — 2016
• Molecular profiling of renal cell carcinoma: building a bridge towards clinical impactBrandon J. Manley, A. Ari Hakimi — 2016
• Dual Chromatin and Cytoskeletal Remodeling by SETD2In Young Park, Reid T. Powell, Durga Nand Tripathi — 2016
• Integration of Recurrent Somatic Mutations with Clinical Outcomes: A Pooled Analysis of 1049 Patients with Clear Cell Renal Cell CarcinomaBrandon J. Manley, Emily C. Zabor, Jozefina Casuscelli — 2016
• Mesothelioma families without inheritance of a BAP1 predisposing mutation.Valeria Ascoli, Ilaria Cozzi, Simona Vatrano — 2016
• High fidelity of driver chromosomal alterations among primary and metastatic renal cell carcinomas: implications for tumor clonal evolution and treatmentErik Kouba, John N. Eble, Novae B. Simper — 2016
• Sarcomatoid renal cell carcinoma: genomic insights from sequencing of matched sarcomatous and carcinomatous componentsBrandon J. Manley, James J. Hsieh — 2016
• Gene of the month: BAP1Ami Wang, Anjali Papneja, Martin Hyrcza — 2016
• Presence of sarcomatoid differentiation as a prognostic indicator for survival in surgically treated metastatic renal cell carcinomaLiangyou Gu, Hongzhao Li, Hanfeng Wang — 2017
• A randomized phase 2 study of MK-2206 versus everolimus in refractory renal cell carcinomaEric Jonasch, Elshad Hasanov, Paul G. Corn — 2017
• Rhabdoid and Undifferentiated Phenotype in Renal Cell Carcinoma: Analysis of 32 Cases Indicating a Distinctive Common Pathway of Dedifferentiation Frequently Associated With SWI/SNF Complex DeficiencyAbbas Agaimy, Liang Cheng, Lars Egevad — 2017
• Comprehensive genomic profiling of salivary mucoepidermoid carcinomas reveals frequent BAP1, PIK3CA, and other actionable genomic alterationsK. Wang, Jessica D. McDermott, Alexa B. Schrock — 2017
• Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic ProfilingAlexa B. Schrock, Shuyu Dan Li, Garrett M. Frampton — 2017
• Comprehensive Analysis of Survival Outcomes in Non–Clear Cell Renal Cell Carcinoma Patients Treated in Clinical TrialsGuillermo de Velasco, Rana R. McKay, Xun Lin — 2017
• Outcomes of Patients with Renal Cell Carcinoma and Sarcomatoid Dedifferentiation Treated with Nephrectomy and Systemic Therapies Over Three Decades: Comparison Between the Cytokine (1987–2005) and the Targeted Therapy (2006–2015) ErasSarp Korcan Keskin, Pavlos Msaouel, Kenneth R. Hess — 2017
• Immune Check Point Inhibition in Sarcomatoid Renal Cell Carcinoma: A New Treatment ParadigmRuben Raychaudhuri, Matthew J. Riese, Kathryn Bylow — 2017
• A comprehensive genomic pan-cancer classification using The Cancer Genome Atlas gene expression dataYuanyuan Li, Kai Kang, J.M. Krahn — 2017
• Renal cell carcinomaJames J. Hsieh, Mark P. Purdue, Sabina Signoretti — 2017
• Preservation of truncal genomic alterations in clear cell and papillary renal cell carcinomas with sarcomatoid features: An intra‐ and intertumoral, multifocal fluorescence in situ hybridization analysis reveals limited genetic heterogeneityJoseph Sanfrancesco, John N. Eble, David J. Grignon — 2017
• Sarcomatoid Renal Cell Carcinoma Has a Distinct Molecular Pathogenesis, Driver Mutation Profile and Transcriptional LandscapeZixing Wang, Tae Beom Kim, Bo Peng — 2017

Related papers

No related papers recorded.